Correction to: Journal of Hematology & Oncology (2019) 12:82 10.1186/s13045-019-0752-3
There is an error in Table 1 of the original article. Lisocabtagene maraleucel (liso-cel) is administered as a flat dose of 1 × 108 CAR T cells, regardless of a patient’s weight. The table incorrectly lists the dose as 1 × 108 cells/kg.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Ayyappan S, Maddocks K. Novel and emerging therapies for B cell lymphoma. J Hematol Oncol. 2019;12(1):82. doi: 10.1186/s13045-019-0752-3. [DOI] [PMC free article] [PubMed] [Google Scholar]